Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
- Resource Type
- Authors
- Elena Munari; Roberto Tonelli; Massimo Girardis; Sophie Venturelli; V. Marco Ranieri; Marianna Meschiari; Lorenzo Dall’Ara; Stefano Busani; Enrico Clini; Andrea Cossarizza; Giovanni Guaraldi
- Source
- Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
- Subject
- Male
Sampling Studie
viral pneumonia
Pulmonary compliance
Severe Acute Respiratory Syndrome
Surface-Active Agent
0302 clinical medicine
Pulmonary surfactant
Retrospective Studie
Medicine
Surfactant replacement
Pharmacology (medical)
030212 general & internal medicine
Letter to the Editor
Respiratory Function Test
intensive care
Middle Aged
Combined Modality Therapy
Respiratory Function Tests
Intensive Care Units
Instillation, Drug
Treatment Outcome
Italy
Viral pneumonia
COVID-19, surfactant, viral pneumonia, intensive care, invasive mechanical ventilation
Coronavirus Infections
Human
Pulmonary and Respiratory Medicine
invasive mechanical ventilation
2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Critical Care
surfactant
Intensive Care Unit
Pneumonia, Viral
Risk Assessment
Sampling Studies
Follow-Up Studie
03 medical and health sciences
Surface-Active Agents
Intensive care
Humans
Intensive care medicine
Pandemics
Aged
Retrospective Studies
lcsh:RC705-779
Pandemic
business.industry
Coronavirus Infection
COVID-19
lcsh:Diseases of the respiratory system
medicine.disease
Respiration, Artificial
Pneumonia
030228 respiratory system
business
Follow-Up Studies
- Language
- English
The reviews of this paper are available via the supplemental material section.